SCHEMBL8098207

SCHEMBL8098207

CS(=O)(=O)Cc1cc(N)nc(-c2ccc(NC(=O)CCC3CC3)cc2)n1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 6/20 0.48
PIK3CA P42336 6/20 0.48
MTOR P42345 4/20 0.45
ALDH1A1 P00352 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
HTT P42858 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
LDLR P01130 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8101525 0.86 TP53 (0.51) PIK3CDPIK3CAMTORALDH1A1KMT2A
SCHEMBL8106097 0.85 PIK3CA (0.46) PIK3CDPIK3CAMTORALDH1A1KMT2A
SCHEMBL8101524 0.84 MEN1 (0.54) PIK3CDPIK3CAMTORALDH1A1KMT2A
SCHEMBL8093349 0.84 PIK3CD (0.48) PIK3CDPIK3CAMTORALDH1A1NPSR1
SCHEMBL8109730 0.83 PIK3CD (0.45) PIK3CDPIK3CAMTORALDH1A1KMT2A
SCHEMBL8099639 0.83 PIK3CA (0.48) PIK3CDPIK3CAMTORNPSR1KMT2A
SCHEMBL3055829 0.82 MTOR (0.70) PIK3CDPIK3CAMTORCYP3A4CYP2C9
SCHEMBL8095869 0.82 PIK3CA (0.46) PIK3CDPIK3CAMTORALDH1A1NPSR1
SCHEMBL8099598 0.82 PIK3CD (0.45) PIK3CDPIK3CAMTORALDH1A1KMT2A
SCHEMBL8103980 0.82 PIK3CA (0.47) PIK3CDPIK3CAMTORALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007749-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed